These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1841778)

  • 1. [The role of plasma lipids and of coagulation factors in atherosclerosis. Clinical trials and new prospects].
    Pagano G; Niort G
    Cardiologia; 1991 Dec; 36(12 Suppl 1):25-32. PubMed ID: 1841778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemostasis and atherosclerosis.
    Warkentin TE
    Can J Cardiol; 1995 May; 11 Suppl C():29C-34C. PubMed ID: 7750046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen: its role in the hemostatic regulation in atherosclerosis.
    Eber B; Schumacher M
    Semin Thromb Hemost; 1993; 19(2):104-7. PubMed ID: 8356454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemostatic variables in the prediction of coronary risk: results of the 8 year follow-up of healthy men in the Münster Heart Study (PROCAM). Prospective Cardiovascular Münster Study.
    Assmann G; Cullen P; Heinrich J; Schulte H
    Isr J Med Sci; 1996 Jun; 32(6):364-70. PubMed ID: 8682642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of thrombotic and hemostatic mechanisms in the initial phases of atherosclerosis].
    Drouet L; Mazoyer E; Bal dit Sollier C; Hainaud P; Ripoll L
    Arch Mal Coeur Vaiss; 1998 Oct; 91 Spec No 5():41-51. PubMed ID: 9833079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fibrinogen as a cardiovascular risk factor].
    Giannasi G; Ferrari S; Galetta F
    Minerva Cardioangiol; 1995 May; 43(5):169-75. PubMed ID: 7478039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Should hemostatic factors be considered in the prevention of cardiovascular disease?].
    Musiał J; Duplaga M
    Pol Tyg Lek; 1993 Aug 2-16; 48(31-33):699-702. PubMed ID: 7971494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Beyond cholesterol levels: new therapeutic indications of statins].
    De Luca N
    Recenti Prog Med; 2001; 92(7-8):429-32. PubMed ID: 11475783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atherosclerotic risk factors in cardiovascular disease.
    LaRosa JC
    J Reprod Med; 1986 Sep; 31(9 Suppl):906-12. PubMed ID: 3772910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of the usefulness of selected biochemical parameters for assessing the advanced atheromatous changes in human coronary arteries].
    Bukowska H
    Ann Acad Med Stetin; 1998; 44():29-43. PubMed ID: 9857530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of fibrinogen and fibrinolysis in peripheral arterial disease.
    Paraskevas KI; Baker DM; Vrentzos GE; Mikhailidis DP
    Thromb Res; 2008; 122(1):1-12. PubMed ID: 17669476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fibrinogen as an independent cardiovascular risk factor and the question of treatment with fibrinogen-lowering drugs].
    Boda Z
    Orv Hetil; 1997 Sep; 138(39):2455-60. PubMed ID: 9380384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of the hemostatic system in pathogenesis of atherosclerosis as the main etiology of coronary ischemia] [corrected].
    Lisowski P; Małyszko J; Lisowska A; Czech B; Myśliwiec M; Jackowski R; Hirnle T
    Pol Merkur Lekarski; 2004 May; 16(95):465-7. PubMed ID: 15518428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid risk factors and atherosclerosis: what do we measure?
    Stein EA
    Scand J Clin Lab Invest Suppl; 1990; 198():3-8. PubMed ID: 2189208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The risk indices for atherothrombotic disease: the coagulation factors].
    Coccheri S
    Ann Ital Med Int; 1991; 6(4):408-15. PubMed ID: 1804286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery Study.
    Tzoulaki I; Murray GD; Price JF; Smith FB; Lee AJ; Rumley A; Lowe GD; Fowkes FG
    Am J Epidemiol; 2006 Feb; 163(4):334-41. PubMed ID: 16357107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemostatic factors in Australian Aboriginal and Torres Strait Islander populations.
    Wang Z; Rowley K; Best J; McDermott R; Taylor M; O'Dea K
    Metabolism; 2007 May; 56(5):629-35. PubMed ID: 17445537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.